WEST PHARMACEUTICAL SERVICES INC (WST)
Data as of , from SEC Form 4 filings.
See up to 3 months of WST. The 7-day demo opens the 1M and 3M ranges and puts WST on your watchlist.
Start 7-day demoLatest WST insider trades
About WEST PHARMACEUTICAL SERVICES INC (WST)
The SEC lists WEST PHARMACEUTICAL SERVICES INC under CIK 0000105770, in surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.
WST Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 6 | 15,659 | $5.44M |
| Grant or award | 7 | 51,842 | |
| Option exercise | 16 | 45,616 | |
WST insider transactions (Form 4)
7856 Form 4 filings on record, the earliest from Oct 31, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Janet Brutschea Haugen - Director | Grant or award | Phantom Stock Unit | 44 | $370.76 | $16K | |
| Annette F. Favorite - Officer | Option exercise | Common Stock | 2,500 | $89.64 | $224K | |
| Annette F. Favorite - Officer | Open-market sale | Common Stock | 2,500 | $345.00 | $863K | |
| Annette F. Favorite - Officer | Option exercise | Common Stock | 2,500 | $89.64 | $224K | |
| Annette F. Favorite - Officer | Open-market sale | Common Stock | 2,500 | $355.00 | $888K | |
| Annette F. Favorite - Officer | Option exercise | Common Stock | 2,524 | $89.64 | $226K | |
| Annette F. Favorite - Officer | Open-market sale | Common Stock | 2,524 | $365.00 | $921K | |
| Annette F. Favorite - Officer | Option exercise | Stock Option (Right to Buy) | 2,500 | $0.00 | - | |
| Annette F. Favorite - Officer | Option exercise | Stock Option (Right to Buy) | 2,500 | $0.00 | - | |
| Annette F. Favorite - Officer | Option exercise | Stock Option (Right to Buy) | 2,524 | $0.00 | - | |
| Annette F. Favorite - Officer | Option exercise | Common Stock | 2,817 | $83.47 | $235K | |
| Annette F. Favorite - Officer | Open-market sale | Common Stock | 2,817 | $340.81 footnote F1 | $960K | |
| Annette F. Favorite - Officer | Option exercise | Common Stock | 2,818 | $83.47 | $235K | |
| Annette F. Favorite - Officer | Open-market sale | Common Stock | 2,818 | $340.81 footnote F1 | $960K | |
| Annette F. Favorite - Officer | Option exercise | Common Stock | 2,500 | $89.64 | $224K | |
| Annette F. Favorite - Officer | Open-market sale | Common Stock | 2,500 | $340.81 footnote F1 | $852K | |
| Annette F. Favorite - Officer | Option exercise | Stock Options (Right to Buy) | 2,817 | $0.00 | - | |
| Annette F. Favorite - Officer | Option exercise | Stock Options (Right to Buy) | 2,818 | $0.00 | - | |
| Annette F. Favorite - Officer | Option exercise | Stock Option (Right to Buy) | 2,500 | $0.00 | - | |
| ||||||
 Michel Lagarde - Officer | Grant or award | Stock Option (Right to Buy) | 13,879 | $0.00 | - | |
| Michel Lagarde - Officer | Grant or award | Stock Option (Right to Buy) | 11,081 | $0.00 | - | |
| Michel Lagarde - Officer | Grant or award | Stock Option (Right to Buy) | 12,088 | $0.00 | - | |
| Michel Lagarde - Officer | Grant or award | Rst. Stock Unit | 6,200 | $0.00 | - | |
| Michel Lagarde - Officer | Grant or award | Rst. Stock Unit | 4,950 | $0.00 | - | |
| Michel Lagarde - Officer | Grant or award | Rst. Stock Unit | 3,600 | $0.00 | - | |
| Robert W. McMahon - Officer | Option exercise | Common Stock | 794.47 | - footnote F1 | - | |
| Robert W. McMahon - Officer | Tax withholding / forfeiture | Common Stock | 345.52 | $351.37 | $121K | |
| Robert W. McMahon - Officer | Option exercise | Common Stock | 6,355 | - footnote F1 | - | |
| Robert W. McMahon - Officer | Tax withholding / forfeiture | Common Stock | 2,764 | $351.37 | $971K | |
| Robert W. McMahon - Officer | Option exercise | Rst. Stock Unit | 6,355 | $0.00 | - | |
| Robert W. McMahon - Officer | Option exercise | Rst. Stock Unit | 794.47 | $0.00 | - | |
| ||||||
| Janet Brutschea Haugen - Director | Grant or award | Phantom Stock Unit | 46 | $359.00 | $17K | |
| Shane Alden Campbell - Officer | Tax withholding / forfeiture | Common Stock | 84.33 | $312.07 | $26K | |
| Shane Alden Campbell - Officer | Tax withholding / forfeiture | Common Stock | 134.93 | $312.07 | $42K | |
| Shane Alden Campbell - Officer | Option exercise | Common Stock | 296 | - footnote F1 | - | |
| Shane Alden Campbell - Officer | Option exercise | Common Stock | 473.59 | - footnote F1 | - | |
| Shane Alden Campbell - Officer | Option exercise | Rst. Stock Unit | 296 | $0.00 | - | |
| Shane Alden Campbell - Officer | Option exercise | Rst. Stock Unit | 473.59 | $0.00 | - | |
| ||||||
| Paolo Pucci - Director | Grant or award | Common Stock | 791 footnote F1 | $0.00 | - | |
| ||||||
| Douglas A. Michels - Director | Grant or award | Common Stock | 791 footnote F1 | $0.00 | - | |
| ||||||
| Stephen H. Lockhart - Director | Grant or award | Common Stock | 791 footnote F1 | $0.00 | - | |
| ||||||
 Goldman Myla Lai - Director | Grant or award | Common Stock | 791 footnote F1 | $0.00 | - | |
| ||||||
| Deborah L. Keller - Director | Grant or award | Common Stock | 791 footnote F1 | $0.00 | - | |
| ||||||
| Molly Joseph - Director | Grant or award | Common Stock | 791 footnote F1 | $0.00 | - | |
| ||||||
| Janet Brutschea Haugen - Director | Grant or award | Common Stock | 791 footnote F1 | $0.00 | - | |
| ||||||
| Robert F. Friel - Director | Grant or award | Common Stock | 791 footnote F1 | $0.00 | - | |
| ||||||
| William F. Feehery - Director | Grant or award | Common Stock | 791 footnote F1 | $0.00 | - | |
| ||||||
| Mark A. Buthman - Director | Grant or award | Common Stock | 791 footnote F1 | $0.00 | - | |
| ||||||
| Annette F. Favorite - Officer | Option exercise | Common Stock | 2,817 | $83.47 | $235K | |
| Annette F. Favorite - Officer | Open-market sale | Common Stock | 2,817 | $305.20 footnote F1 | $860K | |
| Annette F. Favorite - Officer | Option exercise | Stock Options (Right to Buy) | 2,817 | $0.00 | - | |
| ||||||
| Chad Winters - Officer | Option exercise | Common Stock | 896 | $173.22 | $155K | |
| Chad Winters - Officer | Open-market sale | Common Stock | 896 | $300.67 footnote F1 | $269K | |
| Chad Winters - Officer | Option exercise | Stock Options (Right to Buy) | 896 | $0.00 | - | |
| ||||||
| Janet Brutschea Haugen - Director | Grant or award | Phantom Stock Unit | 52 | $250.64 | $13K | |
| Norman D. Finch Jr. - Officer | Grant or award | Rst. Stock Unit | 1,285 | $0.00 | - | |
| Norman D. Finch Jr. - Officer | Grant or award | Stock Option (Right to Buy) | 3,057 | $0.00 | - | |
| Eric Mark Green - Officer | Grant or award | Rst. Stock Unit | 6,986 | $0.00 | - | |
| Eric Mark Green - Officer | Grant or award | Stock Option (Right to Buy) | 16,630 | $0.00 | - | |
| Annette F. Favorite - Officer | Grant or award | Rst. Stock Unit | 720 | $0.00 | - | |
| Annette F. Favorite - Officer | Grant or award | Stock Option (Right to Buy) | 1,712 | $0.00 | - | |
| Shane Alden Campbell - Officer | Grant or award | Rst. Stock Unit | 1,131 | $0.00 | - | |
| Shane Alden Campbell - Officer | Grant or award | Stock Option (Right to Buy) | 2,691 | $0.00 | - | |
| Robert W. McMahon - Officer | Grant or award | Stock Option (Right to Buy) | 7,337 | $0.00 | - | |
| Robert W. McMahon - Officer | Grant or award | Rst. Stock Unit | 3,082 | $0.00 | - | |
| Rodolphe Jean Poussot - Officer | Grant or award | Rst. Stock Unit | 437 | $0.00 | - | |
| Rodolphe Jean Poussot - Officer | Grant or award | Stock Option (Right to Buy) | 1,040 | $0.00 | - | |
| Chad Winters - Officer | Grant or award | Rst. Stock Unit | 340 | $0.00 | - | |
| Chad Winters - Officer | Grant or award | Stock Option (Right to Buy) | 808 | $0.00 | - | |
| Rodolphe Jean Poussot - Officer | Tax withholding / forfeiture | Common Stock | 129.55 | $241.12 | $31K | |
| Rodolphe Jean Poussot - Officer | Option exercise | Common Stock | 383.38 | - footnote F1 | - | |
| Rodolphe Jean Poussot - Officer | Option exercise | Rst. Stock Unit | 383.38 | $0.00 | - | |
| ||||||
| Charles Witherspoon - Officer | Tax withholding / forfeiture | Common Stock | 22.07 | $241.12 | $5K | |
| Charles Witherspoon - Officer | Option exercise | Common Stock | 60.22 | - footnote F1 | - | |
| Charles Witherspoon - Officer | Option exercise | Rst. Stock Unit | 60.22 | $0.00 | - | |
| ||||||
| Chad Winters - Officer | Tax withholding / forfeiture | Common Stock | 30.18 | $241.12 | $7K | |
| Chad Winters - Officer | Option exercise | Common Stock | 89.33 | - footnote F1 | - | |
| Chad Winters - Officer | Option exercise | Rst. Stock Unit | 89.33 | $0.00 | - | |
| ||||||
Item 2.02, 7.01, 9.01
Item 1.01, 9.01
Item 5.02, 7.01, 9.01
Item 9.01
Recent WST Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
WST insider trading FAQ
What is the latest insider trade for WST?
WEST PHARMACEUTICAL SERVICES INC (WST) had 5 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for WST runs to 56 Form 4 filings, the earliest from 2024-10-31. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying WST stock?
No insider purchases of WST were filed in the last 90 days.
How many insiders are selling WST stock?
6 insider sales of WST were filed in the last 90 days, totaling $5.44M.
Where can I see WST SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects WST Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Janet Brutschea Haugen view on EDGAR
- - Annette F. Favorite view on EDGAR
- - Annette F. Favorite view on EDGAR
- - Michel Lagarde view on EDGAR
- - Robert W. McMahon view on EDGAR
- - Janet Brutschea Haugen view on EDGAR
- - Shane Alden Campbell view on EDGAR
- - Paolo Pucci view on EDGAR
- - Douglas A. Michels view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where WST's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow WST with a 7-day demo
- WST on your watchlist
- Every WST Form 4 filing on record
- Up to 3 months of WST price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
